These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 372614)

  • 1. [Etiology of thromboembolism and the role of blood platelets].
    Maekawa T; Kobayashi N
    Nihon Rinsho; 1978 Dec; 36(12):3764-70. PubMed ID: 372614
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanism of platelet aggregation and release: their possible role in vascular injury.
    Ardlie NG
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):891-905. PubMed ID: 4610504
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of platelets in atherosclerosis.
    Sinzinger H
    Semin Thromb Hemost; 1986 Apr; 12(2):124-33. PubMed ID: 3738529
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemostasis, thrombosis, and thromboembolic disorders. The role of arachidonic acid metabolites in platelet-vessel wall interactions.
    Harlan JM; Harker LA
    Med Clin North Am; 1981 Jul; 65(4):855-80. PubMed ID: 6792433
    [No Abstract]   [Full Text] [Related]  

  • 5. Thrombotic complications in thalassemic patients: contribution of red blood cells and platelets.
    Shenkman B
    Thromb Haemost; 2008 Nov; 100(5):735. PubMed ID: 18989511
    [No Abstract]   [Full Text] [Related]  

  • 6. Eicosanoid balance at early stages of experimental atherosclerosis. Its relationship with plasma fibrinolytic activity and platelet aggregation.
    Korbut R; Zmuda A; Basista M; Gryglewski RJ
    Agents Actions Suppl; 1986; 20():225-36. PubMed ID: 3544742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of antiplatelet and antithrombotic drugs.
    Verstraete M; Dejana E; Fuster V; Lapetina E; Moncada S; Mustard JF; Tans G; Vargaftig BB
    Haemostasis; 1985; 15(2):89-99. PubMed ID: 3159632
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of prostaglandin and prostacyclin antagonism at platelet receptors by aggregometry.
    Eggerman TL; Harker LA; Andersen NH; Wilson CH
    Adv Prostaglandin Thromboxane Res; 1980; 6():389-93. PubMed ID: 6247888
    [No Abstract]   [Full Text] [Related]  

  • 9. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation.
    Smith JB; Araki H; Lefer AM
    Circulation; 1980 Dec; 62(6 Pt 2):V19-25. PubMed ID: 7002350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood platelets and cardiovascular diseases. IV. Platelet-inhibiting drugs and antithrombotic agents].
    Jobin F
    Union Med Can; 1976 Aug; 105(8):1159-73. PubMed ID: 10662
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug therapy of vasculitis with prostaglandins].
    Makino S
    Nihon Rinsho; 1985 Oct; 43(10):2200-5. PubMed ID: 3912548
    [No Abstract]   [Full Text] [Related]  

  • 12. [Determination of TXA2 formed by blood platelets and PGX formed by blood vessels and formation of thrombi].
    Srivastava KC
    Ugeskr Laeger; 1977 Nov; 139(47):2815-6. PubMed ID: 339456
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro inhibition by endotoxin of the anti-aggregatory action of prostacyclin produced by aortic rings.
    Bult H; Herman AG
    Arch Int Pharmacodyn Ther; 1978 Aug; 234(2):335-6. PubMed ID: 361006
    [No Abstract]   [Full Text] [Related]  

  • 14. [Functional changes in thrombocytes during heat incubation].
    Volkova RI; Koroleva SA; Lisovskaia IL; Pozin EIa
    Fiziol Zh SSSR Im I M Sechenova; 1974 Feb; 60(2):218-24. PubMed ID: 4459159
    [No Abstract]   [Full Text] [Related]  

  • 15. Platelets and diabetic vascular disease.
    Paton RC; Passa P
    Diabete Metab; 1983 Dec; 9(4):306-12. PubMed ID: 6230270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proceedings: Refractoriness in blood platelets: effect of prior exposure to aggregating agents on subsequent aggregation responses.
    Evans RJ; Gordon JL
    Br J Pharmacol; 1974 May; 51(1):123P. PubMed ID: 4441772
    [No Abstract]   [Full Text] [Related]  

  • 17. Annual oration on small cells and great problems.
    Born GV
    Trans Med Soc Lond; 1982-1984; 99-100():44-52. PubMed ID: 6765412
    [No Abstract]   [Full Text] [Related]  

  • 18. [Interactions between the platelets and the vessel wall. Part 1: Physiology (author's transl)].
    Tobelem G; Drouet L; Caen J
    Nouv Presse Med; 1980 Mar; 9(13):949-54. PubMed ID: 6987618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of flurbiprofen on platelet functions. Study of its interference with the synthesis of platelet thromboxane and production of prostacyclin by the rabbit aorta].
    Levy-Toledano S; Maclouf J; Caen J; Bara L; Lecrubier C; Samama M
    J Pharmacol; 1983; 14(2):141-50. PubMed ID: 6408316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelets and drugs.
    Sheehy TW
    J Med Assoc State Ala; 1976 Apr; 45(9):29-34. PubMed ID: 1031175
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.